An Overview of Dipentum and Breastfeeding
It is not known if
Dipentum® (
olsalazine sodium) is passed through breast milk. However, because of the potentially serious side effects that could occur in the nursing infant, the manufacturer recommends that Dipentum be used with caution in women who are breastfeeding. Therefore, if you are breastfeeding or thinking of breastfeeding, make sure to let your healthcare provider know.
What Does the Research Say About Dipentum and Breastfeeding?
No research has been done to see if Dipentum passes through breast milk in humans. However, it is likely that some of the byproducts of the drug pass through breast milk. The Dipentum molecule itself is inactive; when it reaches the
colon, bacteria enzymes split the molecule, releasing the active forms of the medication. Studies suggest that the active forms of the medication are likely to pass through breast milk. If your healthcare provider recommends Dipentum while breastfeeding, be sure to watch for
diarrhea and any other side effects in your child.
Talking With Your Healthcare Provider About Dipentum and Breastfeeding
You should talk with your healthcare provider about Dipentum and breastfeeding. Everyone's situation is different, and your healthcare provider understands your situation best. After considering what you want and expect, as well as your current health situation, you and your healthcare provider can make a shared decision about Dipentum and breastfeeding that is right for you.
Add this article to your Favorites
Email this article
Print